Baran Akagunduz

发表

Systemic treatment for triple negative breast cancer in older patients: A Young International Society of Geriatric Oncology Review Paper.

J. Marinho, W. Chan, E. Soto-Pérez-de-Celis, 2022, Journal of geriatric oncology.

Efficacy of regorafenib in the second-and third-line setting for patients with advanced hepatocellular carcinoma: A real life data of multicenter study from Turkey.

A. Bilici, S. Şahin, I. Çiçin, 2020, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

Effects of adenosine triphosphate on vandetanib induced skin damage in rats

B. Suleyman, H. Suleyman, R. Mammadov, 2020, Cutaneous and ocular toxicology.

Effect of Adjuvant Chemotherapy in Stage III Cervical Cancer Patients Treated with Concurrent Chemoradiation: A Multicenter Study

I. Cil, N. Ozyurt, A. Onder, 2022, Oncology Research and Treatment.

Tailoring adjuvant chemotherapy by circulating tumor DNA (ctDNA) in older patients with stage II-III colon cancer.

A. Tatlı, I. Okten, D. Guven, 2022, Journal of geriatric oncology.

Controlling Nutritional Status (CONUT) Score Is a Prognostic Factor for Patients with Gastric Cancer Treated by Perioperative FLOT

Baran Akagunduz, Metin Demir, Muhammet Mustafa Atcı, 2021, Journal of Gastrointestinal Cancer.

Protective effects of taxifolin on pazopanib-induced liver toxicity: an experimental rat model

Muhammet Ozer, B. Suleyman, H. Suleyman, 2020, Experimental animals.

Advance Publication Experimental Animals

Bahadır, F. Sugiyama, Kanako Kato, 2020 .

Assessment of abuse and related factors in older patients with cancer

I. Cil, Z. Altın, Yusuf Arslan, 2021, Supportive Care in Cancer.

Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

I. Cil, O. Avci, A. Aydıner, 2021, Tumori.

Comparison of HER2-zero and HER2-low in terms of clinicopathological factors and survival in early-stage breast cancer: A systematic review and meta-analysis.

Baran Akagunduz, G. Ucar, Y. Ergun, 2023, Cancer treatment reviews.

Anal cancer in older adults: A Young International Society of Geriatric Oncology review paper.

B. Martinez-Cannon, J. Marinho, E. Soto-Pérez-de-Celis, 2022, Journal of geriatric oncology.

The impact of adjuvant oxaliplatin and tumor sidedness on the overall survival of stage IIB colon cancer patients: a multicentre study

I. Cil, N. Ozyurt, Muhammet Ozer, 2022, Journal of chemotherapy.

Efficacy and safety of concomitant chemo-endocrine therapy in neoadjuvant treatment of hormone-positive HER2-negative breast cancer: a systemic review and meta-analysis

Baran Akagunduz, G. Ucar, Y. Ergun, 2023, Expert opinion on drug safety.

Adoptive Cell Therapy in Hepatocellular Carcinoma: A Review of Clinical Trials

Andrew J. T. George, I. Sahin, Muhammet Ozer, 2023, Cancers.

Determining the Current Situation of Geriatric Oncology in Turkey: A Survey of Medical Oncologists

I. Cil, Muhammet Ozer, S. Kılıçkap, 2021 .

Major and minor salivary gland cancers: A multicenter retrospective study

H. Harputluoglu, O. Yazıcı, M. Gumus, 2023, Head & neck.

Recommendations of the International Society of Geriatric Oncology on skin cancer management in older patients.

V. del Marmol, G. Colloca, S. Aspeslagh, 2023, Journal of geriatric oncology.

The Effect of HER2-Low Status on Pathological Complete Response and Survival in Triple-Negative Breast Cancer: A Systemic Review and Meta-Analysis.

C. Karaçin, Baran Akagunduz, Sema Turker, 2023, Clinical breast cancer.

Tuberculous Lymphadenitis in a Patient Receiving PD-1 Inhibitor for Melanoma: A Case Report and Brief Literature Review

B. Lebe, Muhammet Ozer, Baran Akagunduz, 2021, Current Oncology.

Highlighting selected research conducted in older patients presented at the European Society for Medical Oncology (ESMO) 2022 Congress - a Young International Society of Geriatric Oncology (SIOG) perspective.

B. Martinez-Cannon, G. Liposits, R. Velasco, 2023, Journal of geriatric oncology.